Insights

Acquisition Opportunity PharmaLex acquisition of Deggegroup signals consolidation in drug safety and pharmacovigilance services, presenting a door to cross-sell Degge Group capabilities to PharmaLex and Safis Solutions customers.

SMB Focus With 11-50 employees and a specialized drug safety consulting profile, Degge is positioned as a target for mid-market pharma and biotech firms seeking scalable pharmacovigilance and outcomes research partnerships.

Global Presence Participation in major international conferences and existing partnerships imply potential for expanded business development through global pharma networks and conference-led lead generation.

Tech Stack Leverage Utilizing cloud and web technologies (Cloudflare, Shopify, jQuery, SEO tooling) offers opportunities to propose digital transformation in safety data management, client portals, and streamlined pharmacovigilance reporting.

Revenue Growth Potential Existing revenue range indicates room for expanded services such as pharmacoeconomics, real-world evidence studies, risk management plans, and compliance analytics for emerging therapeutics.

The Degge Group, Ltd. Tech Stack

The Degge Group, Ltd. uses 8 technology products and services including Unpkg, CIVIC, Lucide, and more. Explore The Degge Group, Ltd.'s tech stack below.

  • Unpkg
    Content Delivery Network
  • CIVIC
    Cookie Compliance
  • Lucide
    Font Scripts
  • Font Awesome
    Font Scripts
  • Preact
    Javascript Libraries
  • Cloudflare Bot Management
    Security
  • Tailwind CSS
    UI Frameworks
  • Apache
    Web Servers

The Degge Group, Ltd.'s Email Address Formats

The Degge Group, Ltd. uses at least 1 format(s):
The Degge Group, Ltd. Email FormatsExamplePercentage
FLast@deggegroup.comJDoe@deggegroup.com
90%
First.Last@deggegroup.comJohn.Doe@deggegroup.com
10%

Frequently Asked Questions

What is The Degge Group, Ltd.'s phone number?

Minus sign iconPlus sign icon
You can contact The Degge Group, Ltd.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is The Degge Group, Ltd.'s official website and social media links?

Minus sign iconPlus sign icon
The Degge Group, Ltd.'s official website is deggegroup.com and has social profiles on LinkedIn.

How much revenue does The Degge Group, Ltd. generate?

Minus sign iconPlus sign icon
As of July 2026, The Degge Group, Ltd.'s annual revenue is estimated to be $1M - $10M.

What is The Degge Group, Ltd.'s NAICS code?

Minus sign iconPlus sign icon
The Degge Group, Ltd.'s NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does The Degge Group, Ltd. have currently?

Minus sign iconPlus sign icon
As of July 2026, The Degge Group, Ltd. has approximately 11 employees across 1 continents, including North America. Key team members include Vice President Finance: P. A.President: J. K. J.. Explore The Degge Group, Ltd.'s employee directory with LeadIQ.

What industry does The Degge Group, Ltd. belong to?

Minus sign iconPlus sign icon
The Degge Group, Ltd. operates in the Pharmaceuticals industry.

What technology does The Degge Group, Ltd. use?

Minus sign iconPlus sign icon
The Degge Group, Ltd.'s tech stack includes UnpkgCIVICLucideFont AwesomePreactCloudflare Bot ManagementTailwind CSSApache.

What is The Degge Group, Ltd.'s email format?

Minus sign iconPlus sign icon
The Degge Group, Ltd.'s email format typically follows the pattern of FLast@deggegroup.com. Find more The Degge Group, Ltd. email formats with LeadIQ.
The Degge Group, Ltd. logo

The Degge Group, Ltd.

PharmaceuticalsVirginia, United States11-50 Employees

The Degge Group, Ltd. is a drug safety consulting and information research firm established in 1988. Based in Fairfax, Virginia, it operates within the pharmaceutical manufacturing sector and offers services across risk evaluation and mitigation strategies, pharmacoepidemiology research, clinical drug safety, safety analyses, pharmacovigilance, pharmacoeconomics and outcomes research. The firm provides specialized consulting and research focused on drug safety and related safety analyses. Its work covers both safety-related evidence generation and the economic and outcomes dimensions of therapeutics.
Degge has engaged with the broader pharmacovigilance and pharmacoepidemiology community through industry conferences, including exhibiting at the ISPOR 21st Annual International Meeting in Washington, DC, in 2016, and at the 32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management in Dublin in 2016. In February 2017, PharmaLex GmbH acquired The Degge Group, Safis Solutions, and Complya Consulting Group, expanding its presence in the United States.

Section iconCompany Overview

Phone number
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
11-50

Section iconFunding & Financials

  • $1M - $10M

    The Degge Group, Ltd.'s revenue is estimated to be in the range of $1M - $10M

Section iconFunding & Financials

  • $1M - $10M

    The Degge Group, Ltd.'s revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.